A company is applying for MAA for a novel immunotherapy, which of the following statements about Module $1$ is not true?

Question $27$Select one:

A$.$Module $1$ is identical across all countries in the EU$.$

B$.$Module $1$ documents are not part of the eCTD dossier.

C$.$Module $1$ refers to compliance with paediatric plans.

D$.$Module $1$ contains Product Information $-$ SmPC$,$ PIL, Labelling, Mock$-$Ups, Specimens, PIL User Testing, Braille.